| 51 |
30317677 | Long noncoding RNA growth arrest-specific 5 facilitates glioma cell sensitivity to cisplatin by suppressing excessive autophagy in an mTOR-dependent manner. | 2019 Apr |
5 |
| 52 |
30528773 | Metformin sensitizes cholangiocarcinoma cell to cisplatin-induced cytotoxicity through oxidative stress mediated mitochondrial pathway. | 2019 Jan 15 |
1 |
| 53 |
30548308 | Long noncoding RNA OIP5-AS1 causes cisplatin resistance in osteosarcoma through inducing the LPAATβ/PI3K/AKT/mTOR signaling pathway by sponging the miR-340-5p. | 2019 Jun |
2 |
| 54 |
30614075 | Core fucosylation of copper transporter 1 plays a crucial role in cisplatin-resistance of epithelial ovarian cancer by regulating drug uptake. | 2019 May |
1 |
| 55 |
30628719 | XPC inhibition rescues cisplatin resistance via the Akt/mTOR signaling pathway in A549/DDP lung adenocarcinoma cells. | 2019 Mar |
1 |
| 56 |
31033054 | Inhibition of PI3K/mTOR increased the sensitivity of hepatocellular carcinoma cells to cisplatin via interference with mitochondrial-lysosomal crosstalk. | 2019 May |
4 |
| 57 |
31079851 | Apatinib enhanced anti-tumor activity of cisplatin on triple-negative breast cancer through inhibition of VEGFR-2. | 2019 Jul |
1 |
| 58 |
31081049 | Icariin enhances the chemosensitivity of cisplatin‑resistant ovarian cancer cells by suppressing autophagy via activation of the AKT/mTOR/ATG5 pathway. | 2019 Jun |
1 |
| 59 |
31094028 | Ginsenoside Rb3 provides protective effects against cisplatin-induced nephrotoxicity via regulation of AMPK-/mTOR-mediated autophagy and inhibition of apoptosis in vitro and in vivo. | 2019 Jul |
3 |
| 60 |
31128031 | A study on the mechanism of rapamycin mediating the sensitivity of pancreatic cancer cells to cisplatin through PI3K/AKT/mTOR signaling pathway. | 2019 Mar-Apr |
7 |
| 61 |
31148231 | p53 induces miR-199a-3p to suppress mechanistic target of rapamycin activation in cisplatin-induced acute kidney injury. | 2019 Oct |
1 |
| 62 |
31234823 | Inhibition of PI3K/Akt/mTOR signaling pathway alleviates ovarian cancer chemoresistance through reversing epithelial-mesenchymal transition and decreasing cancer stem cell marker expression. | 2019 Jun 24 |
2 |
| 63 |
31320816 | Squalene attenuates the oxidative stress and activates AKT/mTOR pathway against cisplatin-induced kidney damage in mice. | 2019 |
2 |
| 64 |
31387554 | Identification of a novel S6K1 inhibitor, rosmarinic acid methyl ester, for treating cisplatin-resistant cervical cancer. | 2019 Aug 6 |
2 |
| 65 |
31405336 | Inhibition of CD133 Overcomes Cisplatin Resistance Through Inhibiting PI3K/AKT/mTOR Signaling Pathway and Autophagy in CD133-Positive Gastric Cancer Cells. | 2019 Jan 1 |
3 |
| 66 |
31411791 | Effects of microRNA-1271 on ovarian cancer via inhibition of epithelial-mesenchymal transition and cisplatin resistance. | 2019 Nov |
1 |
| 67 |
31516578 | MicroRNA-101 modulates cisplatin chemoresistance in liver cancer cells via the DNA-PKcs signaling pathway. | 2019 Oct |
2 |
| 68 |
31608140 | Dual-Targeting AKT2 and ERK in cancer stem-like cells in neuroblastoma. | 2019 Sep 24 |
2 |
| 69 |
31612051 | Polyphyllin I and VII potentiate the chemosensitivity of A549/DDP cells to cisplatin by enhancing apoptosis, reversing EMT and suppressing the CIP2A/AKT/mTOR signaling axis. | 2019 Nov |
1 |
| 70 |
31703757 | Inhibitory effects of polyphyllins I and VII on human cisplatin-resistant NSCLC via p53 upregulation and CIP2A/AKT/mTOR signaling axis inhibition. | 2019 Oct |
1 |
| 71 |
31729456 | Aspirin enhances cisplatin sensitivity of resistant non-small cell lung carcinoma stem-like cells by targeting mTOR-Akt axis to repress migration. | 2019 Nov 15 |
1 |
| 72 |
31786876 | Acetylshikonin inhibits in vitro and in vivo tumorigenesis in cisplatin-resistant oral cancer cells by inducing autophagy, programmed cell death and targeting m-TOR/PI3K/Akt signalling pathway. | 2019 Sep-Oct |
1 |
| 73 |
31878245 | Ovatodiolide Suppresses Oral Cancer Malignancy by Down-Regulating Exosomal Mir-21/STAT3/β-Catenin Cargo and Preventing Oncogenic Transformation of Normal Gingival Fibroblasts. | 2019 Dec 24 |
1 |
| 74 |
29456744 | Cardamonin enhances the anti-proliferative effect of cisplatin on ovarian cancer. | 2018 Mar |
2 |
| 75 |
29535821 | NVP-BEZ235 synergizes cisplatin sensitivity in osteosarcoma. | 2018 Feb 13 |
2 |
| 76 |
29736216 | Rab5a suppresses autophagy to promote drug resistance in cancer cells. | 2018 |
1 |
| 77 |
29808802 | Flavored Guilu Erxian decoction inhibits the injury of human bone marrow mesenchymal stem cells induced by cisplatin. | 2018 May 15 |
1 |
| 78 |
29847773 | Metformin enhances cisplatin induced inhibition of cholangiocarcinoma cells via AMPK-mTOR pathway. | 2018 Aug 15 |
1 |
| 79 |
29959912 | SAHA and cisplatin sensitize gastric cancer cells to doxorubicin by induction of DNA damage, apoptosis and perturbation of AMPK-mTOR signalling. | 2018 Sep 15 |
1 |
| 80 |
30066933 | Co-treatment with BEZ235 enhances chemosensitivity of A549/DDP cells to cisplatin via inhibition of PI3K/Akt/mTOR signaling and downregulation of ERCC1 expression. | 2018 Oct |
1 |
| 81 |
30111296 | Targeting colorectal cancer cell metabolism through development of cisplatin and metformin nano-cubosomes. | 2018 Aug 15 |
1 |
| 82 |
30129654 | PCNA-associated factor P15PAF , targeted by FOXM1, predicts poor prognosis in high-grade serous ovarian cancer patients. | 2018 Dec 1 |
2 |
| 83 |
30280766 | MiR-100 up-regulation enhanced cell autophagy and apoptosis induced by cisplatin in osteosarcoma by targeting mTOR. | 2018 Sep |
2 |
| 84 |
30374107 | The protective effects of maltol on cisplatin-induced nephrotoxicity through the AMPK-mediated PI3K/Akt and p53 signaling pathways. | 2018 Oct 29 |
1 |
| 85 |
30402851 | Regulation of mTOR by miR-107 to facilitate glioma cell apoptosis and to enhance cisplatin sensitivity. | 2018 Oct |
1 |
| 86 |
31938149 | Knockdown of SALL4 overcomes cisplatin-resistance through AKT/mTOR signaling in lung cancer cells. | 2018 |
1 |
| 87 |
27433879 | Effect of autophagy on cisplatin-induced bladder cancer cell apoptosis. | 2017 Mar |
2 |
| 88 |
27799485 | Protein Kinase Cδ Suppresses Autophagy to Induce Kidney Cell Apoptosis in Cisplatin Nephrotoxicity. | 2017 Apr |
3 |
| 89 |
28035350 | Silencing LPAATβ inhibits tumor growth of cisplatin-resistant human osteosarcoma in vivo and in vitro. | 2017 Feb |
1 |
| 90 |
28161641 | Neferine reduces cisplatin-induced nephrotoxicity by enhancing autophagy via the AMPK/mTOR signaling pathway. | 2017 Mar 11 |
1 |
| 91 |
28197628 | Resveratrol-induced autophagy and apoptosis in cisplatin-resistant human oral cancer CAR cells: A key role of AMPK and Akt/mTOR signaling. | 2017 Mar |
1 |
| 92 |
28223119 | Neferine augments therapeutic efficacy of cisplatin through ROS- mediated non-canonical autophagy in human lung adenocarcinoma (A549 cells). | 2017 May |
2 |
| 93 |
28422725 | MiR-199a-3p enhances cisplatin sensitivity of cholangiocarcinoma cells by inhibiting mTOR signaling pathway and expression of MDR1. | 2017 May 16 |
2 |
| 94 |
28459375 | Silencing long non-coding RNA ROR improves sensitivity of non-small-cell lung cancer to cisplatin resistance by inhibiting PI3K/Akt/mTOR signaling pathway. | 2017 May |
2 |
| 95 |
28521459 | Cisplatin regulates cell autophagy in endometrial cancer cells via the PI3K/AKT/mTOR signalling pathway. | 2017 May |
3 |
| 96 |
28693382 | miR-7 Increases Cisplatin Sensitivity of Gastric Cancer Cells Through Suppressing mTOR. | 2017 Dec |
3 |
| 97 |
28737828 | TAZ inhibition restores sensitivity of cisplatin via AKT/mTOR signaling in lung adenocarcinoma. | 2017 Sep |
4 |
| 98 |
28939129 | Salvianolic acid A reverses cisplatin resistance in lung cancer A549 cells by targeting c-met and attenuating Akt/mTOR pathway. | 2017 Sep |
2 |
| 99 |
28979680 | Low concentration of chloroquine enhanced efficacy of cisplatin in the treatment of human ovarian cancer dependent on autophagy. | 2017 |
2 |
| 100 |
29033791 | Protein Synthesis Inhibition and Activation of the c-Jun N-Terminal Kinase Are Potential Contributors to Cisplatin Ototoxicity. | 2017 |
2 |